Showing results (71-80 of 609) with videos related to
Sort By:
Pageof 61
Clinical Lipidology|May 26, 2015
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitorsJixin Zhong, Andrei Maiseyeu, Sanjay RajagopalanAtherosclerosis|October 23, 2012
An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular diseaseJixin Zhong, Xiaoquan Rao, Sanjay RajagopalanNature Clinical Practice. Cardiovascular Medicine|May 27, 2006
Technology insight: Clinical role of magnetic resonance angiography in the diagnosis and management of renal artery stenosisSanto Dellegrottaglie, Javier Sanz, Sanjay RajagopalanBlood Purification|December 20, 2005
Vascular calcification in patients with chronic kidney diseaseSanto Dellegrottaglie, Javier Sanz, Sanjay RajagopalanCurrent Opinion in Lipidology|July 30, 2016
Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studiesJixin Zhong, Saumya Kankanala, Sanjay RajagopalanInternational Journal of Cardiology|July 5, 2015
Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent functionQuan Gong, Sanjay Rajagopalan, Jixin ZhongCirculation Research|April 25, 2024
Understanding the Cardiovascular and Metabolic Health Effects of Air Pollution in the Context of Cumulative Exposomic ImpactsHaitham Khraishah, Zhuo Chen, Sanjay RajagopalanCardiology Clinics|August 9, 2005
Vascular calcification in patients with renal failure: culprit or innocent bystander?Santo Dellegrottaglie, Rajiv Saran, Sanjay RajagopalanDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 4, 2015
Emerging utility of once-weekly exenatide in patients with type 2 diabetesAditya Goud, Jixin Zhong, Sanjay RajagopalanAmerican Journal of Hypertension|February 10, 2015
Air Pollution and Emergency Department Visits for Hypertension in Edmonton and Calgary, Canada: A Case-Crossover StudyRobert D Brook, Termeh KoushaPageof 61